Related Experiment Video
Updated: May 14, 2025

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Irreversible vision loss in antiphospholipid syndrome complicated by pre-eclampsia: a case presentation and
Sara Mirzaeian1, Saeed Zarrabi2, Mahdieh Mottaghi3
1Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Insights
This case study details a pregnant patient with antiphospholipid syndrome (APS) who experienced irreversible vision loss due to severe pre-eclampsia, despite standard anticoagulant therapy. It emphasizes the need for vigilant monitoring and intervention in high-risk pregnancies.
Area of Science:
- Obstetrics and Gynecology
- Ophthalmology
- Rheumatology
Background:
- Pre-eclampsia can cause reversible visual disturbances.
- Antiphospholipid syndrome (APS) is a known risk factor for obstetric complications.
- Severe pre-eclampsia in APS patients can lead to catastrophic outcomes.
Purpose of the Study:
- To present a case of irreversible visual loss in a patient with severe pre-eclampsia and APS.
- To highlight the limitations of standard prophylactic treatment in preventing severe maternal morbidity.
- To underscore the importance of close monitoring and timely intervention in high-risk pregnancies.
Main Methods:
- Case report of an 18-year-old woman with APS, gravida 2, abortion 1.
- Diagnosis of severe pre-eclampsia at 34 weeks gestation with highly triple positive antiphospholipid antibodies.
- Management included aspirin, enoxaparin, cesarean section, and subsequent ophthalmologic interventions.
Main Results:
- The patient developed bilateral visual loss secondary to serous retinal detachment and acute angle-closure glaucoma.
- Despite treatment, vision did not recover, resulting in legal blindness at five-year follow-up.
- This outcome occurred despite prophylactic aspirin and low molecular weight heparin (LMWH) therapy.
Conclusions:
- Pregnant women with APS require meticulous monitoring for pre-eclampsia, even with standard anticoagulant prophylaxis.
- Early and aggressive intervention is crucial to prevent severe visual impairment and other catastrophic outcomes.
- This case emphasizes the need for tailored management strategies in high-risk pregnancies.
Background:
Previous literature has reported cases of reversible visual loss associated with pre-eclampsia. Here, we present a patient with severe pre-eclampsia and a history of antiphospholipid syndrome (APS) who experienced irreversible visual loss.
Case Presentation:
An 18-year-old woman, gravida 2, abortion 1, with a history of antiphospholipid syndrome, was diagnosed with severe pre-eclampsia at 34 weeks of gestation. The patient had highly triple positive antiphospholipid antibodies and was on aspirin and enoxaparin 40 mg daily throughout her pregnancy. Despite timely cesarean section and control of blood pressure, the patient developed bilateral visual loss due to serous retinal detachment and acute angle-closure glaucoma. Although the patient received ophthalmologic interventions, anticoagulant, and immunosuppressive therapy, her vision failed to recover, and at five years of follow-up, the patient remained legally blind.
Conclusion:
Our case highlights the importance of monitoring pregnant women with APS who, despite receiving aspirin and LMWH treatments throughout pregnancy, still present with pre-eclampsia. This underscores the need for proper prophylaxis and timely interventions to prevent catastrophic outcomes.
More Related Videos
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways
Angle Closure Glaucoma: Treatment